Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
<h4>Background</h4>Pulmonary hypertension (PH) is a serious disease with poor prognosis. Reports show that cells in remodeled pulmonary arteries of PH patients have similar characteristics to cancer cells, such as exuberant inflammation, increased proliferation, and decreased apoptosis....
Saved in:
| Main Authors: | Beidi Lan, Emiko Hayama, Nanako Kawaguchi, Yoshiyuki Furutani, Toshio Nakanishi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117211&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospective In Vitro Models of Channelopathies and Cardiomyopathies
by: Nanako Kawaguchi, et al.
Published: (2012-01-01) -
Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01) -
Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.
by: Olga Rafikova, et al.
Published: (2016-01-01) -
Beneficial effects of magnesium nitrate on disease severity in male rats with monocrotaline‐induced pulmonary hypertension
by: Masashi Tawa, et al.
Published: (2025-06-01) -
The Correlation between Lung Ultrasound and Pathology in Rat Model of Monocrotaline-Induced Pulmonary Hypertension
by: Yan-Fen Zhong, et al.
Published: (2024-01-01)